The Day In Review: Broad “Orderly” Decline

In tandem, markets dropped just over half a percentage point on Tuesday. The Centient Biotech 200 was off by 23.36 points, a drop of .67%, while the NYSE composite was lower by .62%, and Nasdaq gave up .74%. We talk about Medarex, which released more good news (and is our “Tip of the Week”), plus Merck and King, which brought unpleasant tidings to the investment public.